BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18495792)

  • 21. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51.
    Ashford DA; di Pietra J; Lingappa J; Woods C; Noll H; Neville B; Weyant R; Bragg SL; Spiegel RA; Tappero J; Perkins BA
    Vaccine; 2004 Sep; 22(25-26):3435-9. PubMed ID: 15308369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for human brucellosis in Iran: a case-control study.
    Sofian M; Aghakhani A; Velayati AA; Banifazl M; Eslamifar A; Ramezani A
    Int J Infect Dis; 2008 Mar; 12(2):157-61. PubMed ID: 17698385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brucellosis in the West Bank, Palestine.
    Husseini AS; Ramlawi AM
    Saudi Med J; 2004 Nov; 25(11):1640-3. PubMed ID: 15573193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory exposures to brucellae and implications for bioterrorism.
    Yagupsky P; Baron EJ
    Emerg Infect Dis; 2005 Aug; 11(8):1180-5. PubMed ID: 16102304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and management of occupational exposures to human immunodeficiency virus (HIV).
    Calfee DP
    Mt Sinai J Med; 2006 Oct; 73(6):852-6. PubMed ID: 17117310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurobrucellosis: four case reports].
    Adeva-Bartolomé MT; Montes-Martínez I; Castellanos-Pinedo F; Zurdo-Hernández JM; de Castro-García FJ
    Rev Neurol; 2005 Dec 1-15; 41(11):664-6. PubMed ID: 16317635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probable transmission of brucellosis by breast milk.
    Arroyo Carrera I; López Rodríguez MJ; Sapiña AM; López Lafuente A; Sacristán AR
    J Trop Pediatr; 2006 Oct; 52(5):380-1. PubMed ID: 16735362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus in the health care setting.
    Wheeler DA
    Occup Med; 1997; 12(4):741-56. PubMed ID: 9353821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National guidelines on management of occupational exposure to HIV.
    Rewari BB; Negi S
    J Indian Med Assoc; 2009 May; 107(5):300-2, 306-7. PubMed ID: 19886385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What is the risk of human immunodeficiency virus infection in health personnel? What are the criteria for postexposure prophylaxis?].
    Fariñas MC; Fariñas-Alvarez C
    Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):541-4. PubMed ID: 10650661
    [No Abstract]   [Full Text] [Related]  

  • 31. Brucellosis and sacroiliitis: a common presentation of an uncommon pathogen.
    Priest JR; Low D; Wang C; Bush T
    J Am Board Fam Med; 2008; 21(2):158-61. PubMed ID: 18343865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A twenty-five year review of laboratory-acquired human infections at the National Animal Disease Center.
    Miller CD; Songer JR; Sullivan JF
    Am Ind Hyg Assoc J; 1987 Mar; 48(3):271-5. PubMed ID: 3578038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina.
    Wallach JC; Ferrero MC; Victoria Delpino M; Fossati CA; Baldi PC
    Clin Microbiol Infect; 2008 Aug; 14(8):805-7. PubMed ID: 18727806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Brucellosis: retrospective evaluation of the clinical, laboratory and epidemiological features of 151 cases].
    Demiroğlu YZ; Turunç T; Alişkan H; Colakoğlu S; Arslan H
    Mikrobiyol Bul; 2007 Oct; 41(4):517-27. PubMed ID: 18173070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public health consequences of a false-positive laboratory test result for Brucella--Florida, Georgia, and Michigan, 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(22):603-5. PubMed ID: 18528317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occupational exposure to blood and body fluids: new postexposure prophylaxis recommendations. United States Occupational Safety and Health Administration.
    Cuny E; Carpenter WM
    J Calif Dent Assoc; 1998 Apr; 26(4):261-7, 269-71. PubMed ID: 9709639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and management of occupational exposure to blood borne viral infections in a resource poor setting: the case for availability of post exposure prophylaxis.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2007 Jun; 10(2):100-4. PubMed ID: 17902499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safer devices preventing occupational blood and body fluid exposures.
    Noone P; Carroll A
    Occup Med (Lond); 2005 Aug; 55(5):404-5. PubMed ID: 16040777
    [No Abstract]   [Full Text] [Related]  

  • 39. Occupational exposure to tuberculosis--OSHA. Proposed rule and notice of public hearing.
    Fed Regist; 1997 Oct; 62(201):54160-308. PubMed ID: 10177300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory-acquired brucellosis.
    Noviello S; Gallo R; Kelly M; Limberger RJ; DeAngelis K; Cain L; Wallace B; Dumas N
    Emerg Infect Dis; 2004 Oct; 10(10):1848-50. PubMed ID: 15504276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.